Targeting endothelial PDGFR‐β facilitates angiogenesis‐associated bone formation through the PAK1/NICD axis
Journal of Cellular Physiology · 2024
DOI: 10.1002/jcp.31291 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular Physiology, 2024. Verfasst von Hancheng Lin und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedics, Division of Orthopaedics and Traumatology, Nanfang Hospital, Southern Medical University, Guangzhou, China. Hauptthemen laut MEDLINE: Receptor, Platelet-Derived Growth Factor beta, p21-Activated Kinases, Osteogenesis, Signal Transduction. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Guangdong Province, China, 2414050005514.
Abstract (Originalsprache)
The intricate orchestration of osteoporosis (OP) pathogenesis remains elusive. Mounting evidence suggests that angiogenesis‐driven osteogenesis serves as a crucial foundation for maintaining bone homeostasis. This study aimed to explore the potential of the endothelial platelet‐derived growth factor receptor‐β (PDGFR‐β) in mitigating bone loss through its facilitation of H‐type vessel formation. Our findings demonstrate that the expression level of endothelial PDGFR‐β is reduced in samples obtained from individuals suffering from OP, as well as in ovariectomy mice. Depletion of PDGFR‐β in endothelial cells ameliorates angiogenesis‐mediated bone formation in mice. The regulatory influence of endothelial PDGFR‐β on H‐type vessels is mediated through the PDGFRβ‐P21‐activated kinase 1‐Notch1 intracellular domain signaling cascade. In particular, the endothelium‐specific enhancement of PDGFR‐β facilitates H‐type vessels and their associated bone formation in OP. Hence, the strategic targeting of endothelial PDGFR‐β emerges as a promising therapeutic approach for the management of OP in the near future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopaedics, Division of Orthopaedics and Traumatology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
- Division of Orthopaedics and Traumatology, Guangdong Provincial Key Laboratory of Bone and Cartilage Regeneration Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, China.
- Department of Sleep Medicine Center, Nanfang Hospital, Southern Medical University, Guangzhou, China.
ORCID-Profile: Ting Xu, Zhuang Cui
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Guangdong Province, China
- 2414050005514
- Science and Technology program of Guangzhou
- Outstanding Youths Development Scheme of Southern Medical University
- Guangdong Basic and Applied Basic Research Foundation
Zitieren
APA
Lin, H., Lin, R., Hou, J., Zhu, C., Liu, G., Lin, Y., Su, J., Yang, M., Yang, B., Ma, Y., Cheng, C., Deng, M., Yu, B., Xu, T., Wu, H., & Cui, Z. (2024). Targeting endothelial PDGFR‐β facilitates angiogenesis‐associated bone formation through the PAK1/NICD axis. Journal of Cellular Physiology. https://doi.org/10.1002/jcp.31291
Vancouver
Lin H, Lin R, Hou J, Zhu C, Liu G, Lin Y, et al. Targeting endothelial PDGFR‐β facilitates angiogenesis‐associated bone formation through the PAK1/NICD axis. Journal of Cellular Physiology. 2024. doi:10.1002/jcp.31291
BibTeX
@article{Lin2024,
author = {Lin, Hancheng and Lin, Rongmin and Hou, Jiahui and Zhu, Chencheng and Liu, Guanqiao and Lin, Yihuang and Su, Jianwen and Yang, Mankai and Yang, Bingsheng and Ma, Yuan and Cheng, Caiyu and Deng, Mingye and Yu, Bin and Xu, Ting and Wu, HangTian and Cui, Zhuang},
title = {Targeting endothelial PDGFR‐β facilitates angiogenesis‐associated bone formation through the PAK1/NICD axis},
journal = {Journal of Cellular Physiology},
year = {2024},
doi = {10.1002/jcp.31291}
}
EUVIMED